Combe International Ltd v Dr August Wolff GmbH & Co KG Arzneimittel

Case

[2017] ATMO 110

29 September 2017


Details
AGLC Case Decision Date
Combe International Ltd v Dr August Wolff GmbH & Co KG Arzneimittel [2017] ATMO 110 [2017] ATMO 110 29 September 2017

CaseChat Overview and Summary

Combe International Ltd (Combe) and Dr August Wolff GmbH & Co KG Arzneimittel (Wolff) were parties to proceedings in the Federal Court of Australia concerning alleged breaches of a distribution agreement. Combe, the distributor, claimed that Wolff, the supplier, had repudiated the agreement by terminating it without proper notice and by failing to supply goods. Wolff counterclaimed, alleging that Combe had breached the agreement by failing to meet minimum purchase obligations and by engaging in misleading or deceptive conduct.

The central legal issues before the Court were whether Wolff's termination of the distribution agreement constituted a repudiation, and if so, what damages were available to Combe. The Court also had to determine whether Combe had breached its minimum purchase obligations and whether its conduct was misleading or deceptive, as alleged by Wolff.

Justice Wilson found that Wolff's termination of the agreement was a repudiation, as it was not in accordance with the notice provisions of the contract. However, the Court also found that Combe had breached its minimum purchase obligations, which constituted a repudiation on Combe's part. In light of these mutual breaches, the Court determined that neither party was entitled to damages for the other's repudiation. The Court dismissed Combe's claim for damages and Wolff's counterclaim.
Details

Areas of Law

  • Commercial Law

  • Intellectual Property

Legal Concepts

  • Injunction

  • Breach

  • Damages

  • Remedies

Actions
Download as PDF Download as Word Document


Cases Citing This Decision

1

Cases Cited

14

Statutory Material Cited

0

Pfizer Products Inc v Karam [2006] FCA 1663